Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in Israel
03:00am, Thursday, 25'th Mar 2021
REHOVOT, Israel and TEL-AVIV, Israel, March 25, 2021 /PRNewswire/ -- Canonic Ltd., a subsidiary of Evogene Ltd.
Evogene's Subsidiary Biomica: Impressive Pre-Clinical Data For Its Microbiome Therapeutic BMC128
06:02pm, Wednesday, 17'th Mar 2021
Biomica released impressive pre-clinical data for its rationally designed 4 strand microbiome therapeutic candidate BMC128 in immuno-oncology presented at the 5th Annual European Microbiome Drug Devel
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q4 2020 Results - Earnings Call Transcript
03:02pm, Wednesday, 03'rd Mar 2021
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q4 2020 Results - Earnings Call Transcript
Evogene: Ambitious Computational Biology Company Aims To Reward Patient Investors
02:03pm, Thursday, 25'th Feb 2021
Evogene Ltd. is a leading computational biology company aiming to "revolutionize" the discovery and development of life sciences products covering human health, agriculture, and industrial purposes.
TEL AVIV and REHOVOT, Israel, Feb. 24, 2021 /PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidiary of Ev
BiomX Inc.: Clinical Stage Phage Therapeutics Company Looks Promising
11:08am, Monday, 22'nd Feb 2021
BiomX Inc.: Clinical Stage Phage Therapeutics Company Looks Promising
REHOVOT, Israel, Jan. 20, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN)
ARKG: Potential Disruption For Healthcare And Pharma Industries
01:56pm, Tuesday, 19'th Jan 2021
ARKG: Potential Disruption For Healthcare And Pharma Industries
Canonic Announces Signing of First Cultivation Agreement for its Medical Cannabis Varieties
07:00am, Wednesday, 23'rd Dec 2020
REHOVOT, Israel, Dec. 23, 2020 /PRNewswire/ -- Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN)
5 Sizzling Stocks to Buy Trading Under $10 With Massive Upside Potential
06:25am, Saturday, 12'th Dec 2020
While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q3 2020 Results - Earnings Call Transcript
03:20pm, Wednesday, 18'th Nov 2020
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q3 2020 Results - Earnings Call Transcript
Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2020
07:00am, Monday, 02'nd Nov 2020
REHOVOT, Israel, Nov. 2, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several
Evogene Prices $12 Million Registered Direct Offering
09:11am, Friday, 30'th Oct 2020
REHOVOT, Israel, Oct. 30, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multip
Evogene: Hidden Gems Of Computational Predictive Biology (Part 3 Of 4) - Ag Plenus (Novel Herbicides And Pesticides)
10:48am, Wednesday, 02'nd Sep 2020
Evogene's 100% owned subsidiary AgPlenus utilizes Evogene's computational predictive biology platform to develop Ag-Chemicals (novel herbicides, insecticides and other crop control products).
Evogene: Hidden Gems Of Computational Predictive Biology, Part 2 Of 4 - Lavie Bio
10:08am, Monday, 24'th Aug 2020
Evogene's 72% owned subsidiary Lavie Bio Ltd. focuses on Microbiome based Ag-biologicals: microbial and naturally derived biostimulants and biopesticides.
